| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9185586 | Thrombosis Research | 2005 | 7 Pages |
Abstract
Heparins potentiate platelet responses to ADP and numerous other agonists. This potentiation is attenuated by cangrelor and A2P5P, and is not mediated by increased dense granule release. ADP receptor antagonists but not aspirin may have potential therapeutic benefits in counteracting the pro-thrombotic effects of heparins.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Robert F. Storey, Jane A. May, Stan Heptinstall,